Tesamorelin + IPA

Tesamorelin 10mg + Ipamorelin 5mg (15mg vial) is a research-grade peptide combination studied for its role in evaluating growth hormone axis signaling, endocrine regulation, and synergistic peptide interactions within controlled laboratory models. In simple terms, researchers use combinations like this to better understand how different pathways involved in growth hormone release may interact when stimulated …

$70.00

Tesamorelin + Ipamorelin is a research-grade peptide combination studied for its role in evaluating growth hormone axis signaling, endocrine regulation, and synergistic peptide interactions within controlled laboratory models. In simple terms, researchers use combinations like this to better understand how different pathways involved in growth hormone release may interact when stimulated through distinct receptor mechanisms.

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that acts on the pituitary gland by binding to GHRH receptors, stimulating endogenous growth hormone secretion and influencing downstream IGF-1 signaling pathways. It is commonly studied in metabolic and endocrine research involving somatotropic axis regulation and lipid metabolism models.

Ipamorelin is a selective growth hormone secretagogue that acts as a ghrelin receptor (GHSR-1a) agonist. It is studied for its ability to stimulate pulsatile growth hormone release through pituitary signaling pathways with high receptor selectivity in research models. Unlike broader secretagogues, Ipamorelin is often evaluated for its targeted activation of growth hormone release pathways without significant interaction with other endocrine axes in preclinical studies.

In combination, Tesamorelin and Ipamorelin are studied for potential synergistic activation of growth hormone release via two distinct upstream mechanisms—GHRH receptor stimulation and ghrelin receptor activation. This dual-pathway approach is used in research to model enhanced pituitary responsiveness and growth hormone secretion dynamics under controlled conditions.

This product is intended strictly for laboratory research purposes only and is not approved for human consumption, medical use, or diagnostic applications.

Key Research Areas

  • Dual-pathway growth hormone secretion studies
  • GHRH and ghrelin receptor signaling interaction
  • Somatotropic axis regulation research
  • IGF-1 downstream pathway modeling
  • Endocrine synergy and pituitary response studies

Chemical Information

  • Compound Name: Tesamorelin + Ipamorelin (IPA)
  • Type: Synthetic peptide blend
  • Components: GHRH analog (Tesamorelin) + GH secretagogue (Ipamorelin)
  • Mechanism: Dual activation of growth hormone release pathways
  • Research Focus: Endocrine signaling and somatotropic axis studies

Important Notice

This compound is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Proper handling and regulatory compliance are required by the purchaser.

Additional information